Join
Live feed
·
INSIDERFilingvia Quantisnow
Paratek Pharmaceuticals Inc. logo

SEC Form 4: Bigham Michael was granted 202,500 shares, increasing direct ownership by 23% to 1,093,282 units

ByQuantisnow·Wall Street's wire, on your screen.
PRTK· Paratek Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRTK (Paratek Pharmaceuticals Inc.) and more on Quantisnow.